Published in Cancer on July 15, 1993
Statement on malignant mesothelioma in the United Kingdom. Thorax (2001) 1.81
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma. J Thorac Dis (2013) 1.27
A novel classification of lung cancer into molecular subtypes. PLoS One (2012) 1.13
Pleural malignant mesothelioma and non-occupational exposure to asbestos in Casale Monferrato, Italy. Occup Environ Med (1995) 1.11
Platelet-derived growth factor (PDGF) BB acts as a chemoattractant for human malignant mesothelioma cells via PDGF receptor beta-integrin alpha3beta1 interaction. Clin Exp Metastasis (1998) 1.08
A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma. Br J Cancer (2004) 1.04
Efficacy of surgical measures in preventing port-site recurrences in a porcine model. Surg Endosc (2001) 1.04
Genome-wide profile of pleural mesothelioma versus parietal and visceral pleura: the emerging gene portrait of the mesothelioma phenotype. PLoS One (2009) 0.96
Non-neoplastic and neoplastic pleural endpoints following fiber exposure. J Toxicol Environ Health B Crit Rev (2011) 0.94
A new electrocautery pleural biopsy technique using an insulated-tip diathermic knife during semirigid pleuroscopy. Surg Endosc (2009) 0.91
Detection of malignant mesothelioma using nuclear structure of mesothelial cells in effusion cytology specimens. Cytometry A (2015) 0.84
Performance of osteopontin in the diagnosis of malignant pleural mesothelioma: a meta-analysis. Int J Clin Exp Med (2014) 0.84
Lung cancer * 8: Management of malignant mesothelioma. Thorax (2003) 0.82
The pleural cavity. BMJ (2000) 0.82
Spontaneous mesotheliomas in F344/N rats are characterized by dysregulation of cellular growth and immune function pathways. Toxicol Pathol (2013) 0.80
Malignant pleural mesothelioma diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration. Tuberc Respir Dis (Seoul) (2013) 0.80
Laparoscopic diagnosis of pleural mesothelioma presenting with pseudoachalasia. World J Gastroenterol (2009) 0.80
Bedside pleuroscopy in Taiwan : a great vision for critically-ill patients and intensivists. Biomedicine (Taipei) (2016) 0.80
Practical approaches to diagnose and treat for T0 malignant pleural mesothelioma: a proposal for diagnostic total parietal pleurectomy. Int J Clin Oncol (2012) 0.76
Update on pleural diseases--2007. Ann Thorac Med (2007) 0.76
Diagnostic Utility of Pleural Fluid Cell Block versus Pleural Biopsy Collected by Flex-Rigid Pleuroscopy for Malignant Pleural Disease: A Single Center Retrospective Analysis. PLoS One (2016) 0.75
Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational study. BMJ Open (2016) 0.75
The journey of mesothelioma: from postmortem to FNA. BMJ Case Rep (2014) 0.75
Giant malignant mesothelioma in the upper mediastinum: A case report. Oncol Lett (2013) 0.75
An Autopsied Case of Malignant Sarcomatoid Pleural Mesothelioma in Which Chest Pain Developed Several Months Earlier without Abnormality on Imaging. Case Rep Oncol (2015) 0.75
Tract metastasis from previously unknown malignant pleural mesothelioma: a case report. Cases J (2009) 0.75
Modern management of malignant pleural mesothelioma. Lung Cancer (Auckl) (2016) 0.75
Diffuse malignant pleural mesothelioma: a multi-institutional clinicopathological study. Surg Today (2008) 0.75
Improved diagnosis and prognostication of patients with pleural malignant mesothelioma using biomarkers in pleural effusions and peripheral blood samples - a short report. Cell Oncol (Dordr) (2017) 0.75
Early mesothelioma revisited. Int J Clin Oncol (2012) 0.75
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science (1983) 43.61
Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV. Proc Natl Acad Sci U S A (1988) 2.47
Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest (1995) 2.29
Identification and antigenicity of the major envelope glycoprotein of lymphadenopathy-associated virus. Virology (1985) 2.23
Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps. J Virol (1995) 2.19
Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases. Chest (1996) 1.91
Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J Virol (1996) 1.84
Nucleotide sequence of HIV1-NDK: a highly cytopathic strain of the human immunodeficiency virus. Gene (1989) 1.83
The flavivirus envelope protein E: isolation of a soluble form from tick-borne encephalitis virus and its crystallization. J Virol (1991) 1.80
A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet (1998) 1.78
Influence of selenium supplements on the post-traumatic alterations of the thyroid axis: a placebo-controlled trial. Intensive Care Med (2001) 1.78
CpG dinucleotides are mutation hot spots in phenylketonuria. Genomics (1989) 1.70
Molecular genetics of phenylketonuria in Mediterranean countries: a mutation associated with partial phenylalanine hydroxylase deficiency. Am J Hum Genet (1989) 1.58
Isolation of human T-lymphotropic retrovirus (LAV) from Zairian married couple, one with AIDS, one with prodromes. Lancet (1984) 1.51
Malignant hyperphenylalaninaemia--current status (June 1977). J Inherit Metab Dis (1978) 1.45
Phenotypically Vif- human immunodeficiency virus type 1 is produced by chronically infected restrictive cells. J Virol (1997) 1.38
Protein engineering of xylose (glucose) isomerase from Actinoplanes missouriensis. 1. Crystallography and site-directed mutagenesis of metal binding sites. Biochemistry (1992) 1.31
Black spots concentrate oncogenic asbestos fibers in the parietal pleura. Thoracoscopic and mineralogic study. Am J Respir Crit Care Med (1996) 1.31
The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB. J Mol Biol (1996) 1.29
Letter: Biopterin derivatives in atypical phenylketonuria. Lancet (1976) 1.27
DNA repair enzyme uracil DNA glycosylase is specifically incorporated into human immunodeficiency virus type 1 viral particles through a Vpr-independent mechanism. J Virol (1999) 1.24
Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients. Medicine (Baltimore) (1999) 1.20
Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: Prognosis and staging. Cancer (1993) 1.17
Guthrie cards for detection of point mutations in phenylketonuria. Lancet (1988) 1.04
Antibody inhibition of the transcriptase activity of the rotavirus DLP: a structural view. J Mol Biol (2001) 1.03
The replicative impairment of Vif- mutants of human immunodeficiency virus type 1 correlates with an overall defect in viral DNA synthesis. J Gen Virol (1998) 1.02
[Partial deficiency of tetrahydrobiopterin]. Arch Fr Pediatr (1983) 1.02
Excretion of pterins in phenylketonuria and phenylketonuria variants. Helv Paediatr Acta (1980) 1.02
Detection of phenylalanine hydroxylase messenger RNA in liver biopsy samples from patients with phenylketonuria. Lancet (1985) 1.00
Spectrum of phenylketonuria mutations in western Europe and north Africa, and their relation to polymorphic DNA haplotypes at the phenylalanine hydroxylase locus. Hum Genet (1991) 0.99
Kinetics of phenylalanine disappearance after intravenous load in phenylketonuria and its genetic variants. Pediatr Res (1979) 0.95
Neuropsychologic functions of early treated patients with phenylketonuria, on and off diet: results of a cross-national and cross-sectional study. Pediatr Res (1997) 0.95
Influence of flow rate on the kinetics of the intestinal absorption of glucose and lysine in children. Gastroenterology (1974) 0.94
Sex reversal effects on Caiman latirostris exposed to environmentally relevant doses of the xenoestrogen bisphenol A. Gen Comp Endocrinol (2003) 0.90
Thoracoscopy in the diagnosis and treatment of spontaneous pneumothorax. Clin Chest Med (1995) 0.89
Serotonin and dopamine synthesis in phenylketonuria. Adv Exp Med Biol (1981) 0.89
Isolation of lymphadenopathy-associated virus (LAV) and detection of LAV antibodies from US patients with AIDS. JAMA (1985) 0.88
Intellectual and school performances in early-treated classical PKU patients. The French collaborative study. Eur J Pediatr (1987) 0.88
Time and space clusters of the French-Canadian M1V phenylketonuria mutation in France. Am J Hum Genet (1992) 0.86
Monitoring of serum levels of imipramine and desipramine and individualization of dose in enuretic children. Ther Drug Monit (1984) 0.86
HIV-I and HIV-II double infection in Central African Republic. Lancet (1986) 0.86
Serotonin deficiency in phenylketonuria embryopathy. Toxicol In Vitro (1995) 0.85
Hormonal control of phenylalanine hydroxylase activity in isolated rat hepatocytes. Biochem Biophys Res Commun (1980) 0.85
Persistence of parvovirus B19 DNA in testis of patients with testicular germ cell tumours. J Gen Virol (1998) 0.85
Hudson memorial lecture. Neonatal management of organic acidurias. Clinical update. J Inherit Metab Dis (1984) 0.85
Breast cancer prognostic significance of some modified urinary nucleosides. Cancer Lett (1996) 0.84
[Malignant mesothelioma: prognostic factors in a series of 125 patients studied from 1973 to 1987]. Bull Acad Natl Med (1992) 0.84
Biopterin defect in a normal-appearing child affected by a transient phenylketonuria. Arch Dis Child (1980) 0.83
Relation between renal function tests and a retrospective organic solvent exposure score. Br J Ind Med (1989) 0.82
Sex steroids modulate the pituitary parameters involved in the regulation of TSH secretion in the rat. Acta Endocrinol (Copenh) (1990) 0.82
Single-strand conformation polymorphism for detection of mutations and base substitutions in phenylketonuria. Am J Hum Genet (1991) 0.82
Cellular differentiation and enzymatic deficits. Lancet (1971) 0.82
Hydrocarbon exposure, hypertension and kidney function tests. Int Arch Occup Environ Health (1990) 0.81
Influence of age on ortho-hydroxyphenylacetic acid excretion in phenylketonuria and its genetic variants. Pediatr Res (1974) 0.81
Atypical phenylketonuria with "dihydrobiopterin synthetase" deficiency: absence of phosphate-eliminating enzyme activity demonstrated in liver. Eur J Pediatr (1985) 0.81
Intraluminal and mucosal starch digestion in congenital deficiency of intestinal sucrase and isomaltase activities. Pediatr Res (1972) 0.81
Lack of gonadotropic response to pulsatile gonadotropin-releasing hormone in isolated hypogonadotropic hypogonadism associated to congenital adrenal hypoplasia. J Endocrinol Invest (1988) 0.81
Effects of droperidol on respiratory drive in humans. Anesthesiology (1983) 0.81
CV 205-502 treatment of macroprolactinomas. J Endocrinol Invest (1991) 0.81
The HIV-1 Vpr co-activator induces a conformational change in TFIIB. FEBS Lett (1999) 0.80
Phenylalanine hydroxylase. Evidence that the enzyme from human liver might not be a phosphoprotein. Biochem Int (1983) 0.80
[Emergency treatment of an acute form of leucinosis by peritoneal dialysis]. Arch Fr Pediatr (1969) 0.80
Glycosaminoglycans, albuminuria and hydrocarbon exposure. Nephron (1991) 0.80
Five novel missense mutations of the phenylalanine hydroxylase gene in phenylketonuria. Hum Mutat (1994) 0.80
Heat shock protein 70 and sex steroid receptors in the follicular structures of induced ovarian cysts. Reprod Domest Anim (2008) 0.80
Dissociated recovery of cortisol and dehydroepiandrosterone sulphate after treatment for Cushing's syndrome. J Endocrinol Invest (1991) 0.79
Origins of hyperphenylalaninemia in Israel. Eur J Hum Genet (1994) 0.79
Two distinct mutations at a single BamHI site in phenylketonuria. J Med Genet (1991) 0.79
Anti-beta 2-microglobulin monoclonal antibodies mediate a delay in HIV1 cytopathic effect on MT4 cells. Res Immunol (1991) 0.79
Linkage disequilibrium between phenylketonuria and RFLP haplotype 1 at the phenylalanine hydroxylase locus in Portugal. Hum Genet (1992) 0.79
Thoracoscopic lung biopsy. Experimental and clinical preliminary study. Chest (1982) 0.79
Atypical phenylketonuria with normal dihydropteridine reductase activity. N Engl J Med (1976) 0.79
Chrysotile and tremolite asbestos fibres in the lungs and parietal pleura of Corsican goats. Occup Environ Med (2002) 0.79
Illegitimate transcription of the phenylalanine hydroxylase gene in lymphocytes for identification of mutations in phenylketonuria. Hum Mol Genet (1993) 0.78
Phenylalanine 4-monooxygenase from human liver. Methods Enzymol (1987) 0.78
Intrapleural immunotherapy with escalating doses of interleukin-2 in metastatic pleural effusions. Cancer (1993) 0.78
A 3-base pair in-frame deletion of the phenylalanine hydroxylase gene results in a kinetic variant of phenylketonuria. J Biol Chem (1991) 0.78
Isolation of HIV in a seronegative demented patient without symptoms of immune deficiency. Cancer Detect Prev (1988) 0.78
[Glomerular erythrocytes, albuminuria, glycosaminoglycans and exposure to hydrocarbons]. Schweiz Med Wochenschr (1990) 0.78
Ectopic ACTH Cushing's syndrome: V3 vasopressin receptor but not CRH receptor gene expression in a pulmonary carcinoid tumor. Horm Res (1998) 0.78
Further evidence for the usefulness of the salivary testosterone radioimmunoassay in the assessment of androgenicity in man in basal and stimulated conditions. Horm Res (1986) 0.78
[Infection of insect cell lines by the HIV virus, an agent of AIDS, and a demonstration of insects of African origin infected by this virus]. C R Acad Sci III (1986) 0.77
Western blot technique in the serological evaluation of three LAV/HTLV III-infected Italian families. Infection (1986) 0.77
The mutant genotype is the main determinant of the metabolic phenotype in phenylalanine hydroxylase deficiency. Mol Genet Metab (1999) 0.77
Novel frame shift deletions of the phenylalanine hydroxylase gene in phenylketonuria. Hum Mol Genet (1994) 0.77
In vivo studies of the tryptophan-5-hydroxylase system. Quantitation of serotonin and tryptamine using gas chromatography-mass fragmentography. J Chromatogr (1980) 0.76
[Idiopathic disorder of intestinal fat transport (Anderson's disease). A further case]. Arch Fr Pediatr (1973) 0.76
Follicle-stimulating hormone bioactivity in idiopathic normogonadotropic oligoasthenozoospermia: double-blind trial with gonadotropin-releasing hormone. Fertil Steril (1992) 0.76
Levobupivacaine plus fentanyl versus racemic bupivacaine plus fentanyl in epidural anaesthesia for lower limb surgery. Minerva Anestesiol (2008) 0.76
Genetic background of clinical homogeneity of phenylketonuria in Poland. J Med Genet (1993) 0.76
Prediction of imipramine serum levels in enuretic children by a Bayesian method: comparison with two other conventional dosing methods. Ther Drug Monit (1989) 0.76
Secretion of extracellular factor(s) induced by X-irradiation activates the HIV type 1 long terminal repeat through its kappaB motif. AIDS Res Hum Retroviruses (1998) 0.76
Enormous cross-reactivity of hydrocortisone hemisuccinate in the "RIANEN" RIA kit for cortisol determination. Clin Chem (1988) 0.76
RE main asbestos type in pleural mesothelioma. Am J Ind Med (1998) 0.76
[Hyperphenylalaninaemia with normal phenylalanine-hydroxylase activity and a deficiency of tetrahydrobiopterin and dihydropteridine reductase]. Arch Fr Pediatr (1978) 0.75
In ovum exposure to pesticides increases the egg weight loss and decreases hatchlings weight of Caiman latirostris (Crocodylia: Alligatoridae). Ecotoxicol Environ Saf (2007) 0.75
An animal model for maternal phenylketonuria. J Med Genet (1991) 0.75
The influence of clinical and pharmacological factors on enuresis treatment with imipramine. Br J Clin Pharmacol (1990) 0.75
[The Combitube as an alternative method when intubation is impossible]. Rev Esp Anestesiol Reanim (1994) 0.75
[Genetic control of enzymes]. Ann Biol Clin (Paris) (1974) 0.75